These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 38645931)

  • 1. Advancing
    Tadjiki S; Sharifi S; Lavasanifar A; Mahmoudi M
    ACS Bio Med Chem Au; 2024 Apr; 4(2):77-85. PubMed ID: 38645931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disentangling Biomolecular Corona Interactions With Cell Receptors and Implications for Targeting of Nanomedicines.
    Aliyandi A; Zuhorn IS; Salvati A
    Front Bioeng Biotechnol; 2020; 8():599454. PubMed ID: 33363128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nano-Bio Interactions in Cancer: From Therapeutics Delivery to Early Detection.
    Liu Y; Wang J; Xiong Q; Hornburg D; Tao W; Farokhzad OC
    Acc Chem Res; 2021 Jan; 54(2):291-301. PubMed ID: 33180454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physiology, pathology and the biomolecular corona: the confounding factors in nanomedicine design.
    Liu K; Salvati A; Sabirsh A
    Nanoscale; 2022 Feb; 14(6):2136-2154. PubMed ID: 35103268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein corona: challenges and opportunities for targeted delivery of nanomedicines.
    Jiang Z; Chu Y; Zhan C
    Expert Opin Drug Deliv; 2022 Jul; 19(7):833-846. PubMed ID: 35738018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How protein coronas determine the fate of engineered nanoparticles in biological environment.
    Capjak I; Goreta SŠ; Jurašin DD; Vrček IV
    Arh Hig Rada Toksikol; 2017 Dec; 68(4):245-253. PubMed ID: 29337683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Crown and the Scepter: Roles of the Protein Corona in Nanomedicine.
    Cai R; Chen C
    Adv Mater; 2019 Nov; 31(45):e1805740. PubMed ID: 30589115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanoparticle protein corona evolution: from biological impact to biomarker discovery.
    Kamaly N; Farokhzad OC; Corbo C
    Nanoscale; 2022 Feb; 14(5):1606-1620. PubMed ID: 35076049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The protein corona on nanoparticles as viewed from a nanoparticle-sizing perspective.
    Wang H; Lin Y; Nienhaus K; Nienhaus GU
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2018 Jul; 10(4):e1500. PubMed ID: 29071798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanoparticle sizing in the field of nanomedicine: Power of an analytical ultracentrifuge.
    Cinar G; Solomun JI; Mapfumo P; Traeger A; Nischang I
    Anal Chim Acta; 2022 May; 1205():339741. PubMed ID: 35414386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanistic Understanding of Protein Corona Formation around Nanoparticles: Old Puzzles and New Insights.
    Nienhaus K; Nienhaus GU
    Small; 2023 Jul; 19(28):e2301663. PubMed ID: 37010040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomolecular Corona Affects Controlled Release of Drug Payloads from Nanocarriers.
    Sharifi S; Caracciolo G; Mahmoudi M
    Trends Pharmacol Sci; 2020 Sep; 41(9):641-652. PubMed ID: 32713606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemical and Biophysical Signatures of the Protein Corona in Nanomedicine.
    Ren J; Andrikopoulos N; Velonia K; Tang H; Cai R; Ding F; Ke PC; Chen C
    J Am Chem Soc; 2022 Jun; 144(21):9184-9205. PubMed ID: 35536591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomolecular Corona Dictates Aβ Fibrillation Process.
    Lotfabadi A; Hajipour MJ; Derakhshankhah H; Peirovi A; Saffar S; Shams E; Fatemi E; Barzegari E; Sarvari S; Moakedi F; Ferdousi M; Atyabi F; Saboury AA; Dinarvand R
    ACS Chem Neurosci; 2018 Jul; 9(7):1725-1734. PubMed ID: 29676567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of protein corona on the biological behavior of targeting nanomedicines.
    Farshbaf M; Valizadeh H; Panahi Y; Fatahi Y; Chen M; Zarebkohan A; Gao H
    Int J Pharm; 2022 Feb; 614():121458. PubMed ID: 35017025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In Situ Characterization of Protein Adsorption onto Nanoparticles by Fluorescence Correlation Spectroscopy.
    Shang L; Nienhaus GU
    Acc Chem Res; 2017 Feb; 50(2):387-395. PubMed ID: 28145686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Overview of Nanoparticle Protein Corona Literature.
    Hajipour MJ; Safavi-Sohi R; Sharifi S; Mahmoud N; Ashkarran AA; Voke E; Serpooshan V; Ramezankhani M; Milani AS; Landry MP; Mahmoudi M
    Small; 2023 Sep; 19(36):e2301838. PubMed ID: 37119440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liposome protein corona characterization as a new approach in nanomedicine.
    Capriotti AL; Cavaliere C; Piovesana S
    Anal Bioanal Chem; 2019 Jul; 411(19):4313-4326. PubMed ID: 30758528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Probing the glycans accessibility in the nanoparticle biomolecular corona.
    Clemente E; Martinez-Moro M; Trinh DN; Soliman MG; Spencer DIR; Gardner RA; Kotsias M; Sánchez Iglesias A; Moya S; Monopoli MP
    J Colloid Interface Sci; 2022 May; 613():563-574. PubMed ID: 35066229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stealth effect of biomolecular corona on nanoparticle uptake by immune cells.
    Caracciolo G; Palchetti S; Colapicchioni V; Digiacomo L; Pozzi D; Capriotti AL; La Barbera G; Laganà A
    Langmuir; 2015 Oct; 31(39):10764-73. PubMed ID: 26378619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.